Ergothioneine: the mushroom antioxidant with real data

Every few years the beauty industry finds a new antioxidant and decides it will replace vitamin C. Most of them do not. Idebenone, resveratrol, coenzyme Q10, they each had their moment and settled into being one option among many. Ergothioneine, the molecule currently being marketed as a “longevity vitamin,” is worth a closer look than that, not because the marketing is right, but because the underlying biology is unusually solid.

Ergothioneine is a sulfur-containing amino acid that your body cannot make. You get it entirely from diet, and the richest source by far is mushrooms; oyster and shiitake mushrooms in particular are loaded with it. That dietary-only status is part of why some researchers have floated the idea that it might be a vitamin we have not formally recognized yet.

The transporter is the whole story

Here is what separates ergothioneine from the parade of antioxidants that came before it. Your cells have a dedicated protein, a transporter called OCTN1, whose job appears to be specifically to pull ergothioneine inside. As the review published in the journal Natural Product Reports and indexed on NCBI lays out, this transporter concentrates ergothioneine in exactly the tissues that take the most oxidative damage: skin, eyes, liver, red blood cells. The body is spending energy to hoard this molecule in the places that need protection most.

That matters because the single biggest problem with topical antioxidants is getting them where they need to go. Vitamin C has to be formulated at a low pH and high concentration just to coax a little of it through the skin barrier, and it degrades on contact with air and light. Ergothioneine does not have that problem. It is water-soluble, stable across a wide pH range, and, as North Biomedical’s breakdown of the ingredient notes, it can reach intracellular compartments, including the mitochondria, that many antioxidants never touch. An antioxidant sitting on the surface of a cell is far less useful than one inside it, next to the machinery that actually generates free radicals.

It does not just mop up, it switches on defenses

The lazy way to describe any antioxidant is “it neutralizes free radicals.” That is true of ergothioneine, but it undersells the more interesting part. The research suggests ergothioneine also works by activating Nrf2, a master switch that turns on a whole suite of the cell’s built-in antioxidant and detox genes. When researchers block that pathway experimentally, ergothioneine loses much of its protective effect, which tells you the molecule is not just a sponge; it is signaling the cell to defend itself.

This is the same mechanism that makes ingredients like sulforaphane (from broccoli sprouts) interesting to dermatologists. A topical that amplifies your skin’s own defense system has a different, and arguably more durable, effect than one that simply gets used up neutralizing one radical per molecule and then is gone.

What the human data actually shows

Mechanism is seductive and frequently misleading, so the question is always: did it do anything measurable in real people? The honest answer is that the human evidence is early but encouraging, and mostly on the oral side so far.

The strongest piece is a 2024 randomized, double-blind, placebo-controlled trial published in Frontiers in Medicine. Eighty healthy women took either a Pleurotus mushroom tablet delivering 25 mg of ergothioneine daily or a placebo, for twelve weeks. The supplemented group showed significantly higher skin moisture at the temple and improvements in facial appearance scores, while their blood levels of ergothioneine rose roughly fivefold. A separate open-label study summarized on BioMed Grid reported similar directional improvements in skin parameters with oral supplementation.

Twelve weeks, eighty people, one trial with a placebo arm. That is a real study, but it is not a mountain of evidence, and “significantly higher moisture at the temple” is a modest, specific finding rather than a dramatic before-and-after. Be suspicious of any brand citing this kind of data to promise you will look ten years younger. The topical skincare data, as opposed to oral, is thinner still and leans heavily on lab models rather than finished-product trials on faces.

How to think about it in a real routine

Treat ergothioneine the way you would treat a good supporting antioxidant, not a hero active. If you already have a retinoid doing the heavy structural work and a daily SPF doing the actual prevention, an antioxidant layer underneath is a reasonable addition, and ergothioneine is a sensible one because it is stable and plays well with other ingredients. It will not sting, it will not pill the way some vitamin C serums do, and it does not fight with niacinamide or peptides.

Where it fits in a makeup context is the same place any good antioxidant serum fits: in the prep layer, underneath everything else. The smoother and more resilient your skin barrier, the better a glass skin finish photographs and the longer a no-makeup makeup look holds without going patchy by afternoon. A well-hydrated base is also what lets a dewy dolphin skin finish read as healthy rather than greasy. None of that requires ergothioneine specifically, but a serum that improves moisture retention contributes to it.

One practical note on the oral versus topical question, since both are sold. The cleanest human data we have, the Frontiers in Medicine trial, used an oral mushroom tablet, not a cream. That does not prove topical ergothioneine is useless; OCTN1 is expressed in the skin, so there is a plausible delivery route. It does mean the strongest evidence is for the supplement form, and that a serum claiming the same benefits is extrapolating. If you eat oyster or shiitake mushrooms regularly, you are already getting a